Stable Isotope Labeled Compounds Market Size
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 3.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Stable Isotope Labeled Compounds Market Analysis
The stable isotope labeled compounds market is projected to witness a CAGR of nearly 3.3% over the forecast period.
The emergence of COVID-19 opened the doors for drastic R&D across the world. Companies were working hard to cope with the coronavirus and understand the effective way to manage the disease. The pandemic had a significant impact on the stable isotope-labeled compounds market as R&D was on the rise. For instance, in June 2020, Cambridge Isotobes Laboratory Inc. announced that the company was assisting the researchers at the Massachusetts Institute of Technology, Cambridge, to investigate the structure and dynamics of membrane proteins found in pathogenic viruses such as SARS-CoV 2 by supplying 3C6 glucose isotope which is used in E. coli-based protein expression to enrich SARS CoV 2 and also with 13C for the general requirement for NMR investigations of this type. As the use of stable isotopes labeled compounds increased for research during the pandemic, it is observed that the market was positively impacted. However, currently, the market is in its pre-pandemic phase and is expected to witness healthy growth in the coming years.
The major factor attributing to the growth of the market include the increase in the incidence of cancer and the growing investments in R&D programs by the biotechnology and pharmaceutical companies are boosting the market growth.
As per the data from the American Cancer Society report published in 2022, it is observed that there will be around 1.91 million new cancer cases in the United States during 2022. Among the cancer cases, cancers of the genital and digestive systems are expected to be the highest, with 395,600 and 343,040 new cases, respectively. The data published by PubMed in August 2021 stated that stable isotope tracing is an essential technology to study the molecular mechanisms by which nutraceuticals modulate and target cancer metabolism. Furthermore, the use of positionally labeled tracers as exogenous nutrients and the monitoring of their downstream metabolites labeling patterns enable the analysis of the specific metabolic pathway activity in cancer. Therefore, with the significance of stable isotopes in cancers, a high incidence of the disease is expected to propel market growth in the coming years.
Furthermore, there is growing research in the proteomics industry, which is augmenting the market growth. For instance, as per the data from the Journal of Proteomics and Bioinformatics data published in September 2022, rapid advancements in proteomics are enabling its high utilization in the treatment of infectious diseases across the world. Protein steady-state levels, protein turnover, and protein localization can all be determined using stable isotope labeling with mass spectrometry (MS)-based proteomic analysis. Hence, with the increasing research in proteomics research and the application of stable isotopes in the same, the market studied is expected to witness strong growth in the forecast period.
However, the high cost of the isotope compounds is the major drawback of the market.
Stable Isotope Labeled Compounds Market Trends
This section covers the major market trends shaping the Stable Isotope Labeled Compounds Market according to our research experts:
Research and Development Segment is Dominating the Stable Isotope Labeled Compounds Market
The growth of the segment is attributed to the increase in R&D spending. Both government and major players are investing in product development. Stable isotope tracers can be safely governed simultaneously to the same subject without compromising future studies. The plasma volume which is needed from one sample to analyze the isotope enrichment is small, allowing even preterm infants to be studied.
The use of enriched stable isotopes and their applications as they are presently known emerges from early work with metabolites labeled with deuterium by Schoenheimer and Rittenberg in 1935. For the last two decades, enriched stable isotopes have offered substantial advantages to scientists and clinicians rapidly involved in the research on human body composition, pathogenies of several diseases, and understanding disease epidemiology. Increased awareness of the role played by the elements in human health and as etiologic factors in diseases (osteoporosis, heart disease, cancer, diabetes, kidney disease), as well as diagnostic and therapeutic adjuncts (obesity, inborn errors of metabolism, heart disease), has created an explosion in need for stable isotopes.
There is increasing activity among pharmaceutical companies in the isotope area. For instance, in August 2021, Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, and TRIUMF, Canada's particle accelerator center, announced that the companies entered into the next phase of their collaboration agreement for the development, production, and supply of actinium-225. Additionally, in December 2021, AIkido Pharma Inc. announced that the company secured a strategic equity interest in ASP Isotopes Inc., which focuses on the non-nuclear supply of enriched isotopes. Hence, with such partnerships, the segment is expected to witness significant growth over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market throughout the forecast period. The market growth is due to factors such as the presence of key players, the high prevalence of cancer in the region, and the established healthcare infrastructure. Furthermore, beneficial government initiatives and increased research partnerships are some of the drivers expected to propel market growth. The United States has the maximum share in this region due to supportive healthcare policies, the high number of patients, and a developed healthcare market.
There has been growing funding for research and development in stable isotopes in the United States. For instance, in October 2022, the US Secretary of Energy visited Oak Ridge National Laboratory to attend a groundbreaking ceremony for the US Stable Isotope Production and Research Center. The facility is slated to receive USD 75 million in funding from the Inflation Reduction Act. With such huge funding for stable isotopes, the market studied is expected to witness significant growth in the forecast period.
Furthermore, as per the data from Frontiers Journal published in August 2021, researchers in the United States are studying the use of stable isotopes in treating pancreatic cancer. The research on stable isotopes in the country is propelling the demand for the same and is contributing significantly to the market growth. Additionally, there is a growing burden of cancers in the United States which is augmenting the market growth.
Stable Isotope Labeled Compounds Industry Overview
The stable isotope labelled compounds market is moderately competitive and consists of several major players. Some of the international companies that are present in this market are PerkinElmer Inc., Merck KGaA, Cambridge Isotope Laboratories Inc., JSC Isotope, Medical Isotopes Inc., Omicron Biochemicals Inc., Trace Sciences International, Alsachim, and Taiyo Nippon Sanso Corporation.
Stable Isotope Labeled Compounds Market Leaders
-
PerkinElmer Inc
-
Merck KGaA
-
Cambridge Isotope Laboratories, Inc.
-
JSC Isotope.
-
Medical Isotopes, Inc.
*Disclaimer: Major Players sorted in no particular order
Stable Isotope Labeled Compounds Market News
- Oct 2022: ORNL announced its contribution to building new facilities to make isotopes used in medical treatments and many other fields. The US Stable Isotope Production and Research Center will enrich stable isotopes used for cancer treatments, heart disease treatments, and space exploration.
- Sept 2022: Cambridge Isotope Laboratories Inc. (CIL) partnered with ISOtopic Solutions to release the new stable isotope-labeled and unlabeled Crude Lipid Yeast Extract.
Stable Isotope Labeled Compounds Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Proteomics Research
- 4.2.2 Rising Prevalence of Cancer
-
4.3 Market Restraints
- 4.3.1 Lack of Skilled Labour
- 4.3.2 High Cost of Stable Isotope-Labeled Compounds
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Type
- 5.1.1 Deuterium
- 5.1.2 Carbon-13
- 5.1.3 Oxygen-18
- 5.1.4 Other Stable Isotopes
-
5.2 By Application
- 5.2.1 Research and Development
- 5.2.2 Clinical Diagnostics
- 5.2.3 Other Applications
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle-East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 PerkinElmer Inc.
- 6.1.2 Merck KGaA
- 6.1.3 Cambridge Isotope Laboratories Inc.
- 6.1.4 JSC Isotope
- 6.1.5 Medical Isotopes Inc.
- 6.1.6 Omicron Biochemicals Inc.
- 6.1.7 Trace Sciences International
- 6.1.8 Alsachim
- 6.1.9 Taiyo Nippon Sanso Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityStable Isotope Labeled Compounds Industry Segmentation
As per the scope of the report, a stable isotope-labeled compound is a chemical substance in which part of the molecules are labeled with an isotope so that observations of the isotopic composition make it possible to follow the compound or its fragments through physical, chemical, or biological processes.
The Stable Isotope Labeled Compounds Market is Segmented by Type (Deuterium, Carbon-13, Oxygen-18, and Other Stable Isotopes), Application (Research and Development, Clinical Diagnostics, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value in USD million for the above segments. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the above segments.
| By Type | Deuterium | |
| Carbon-13 | ||
| Oxygen-18 | ||
| Other Stable Isotopes | ||
| By Application | Research and Development | |
| Clinical Diagnostics | ||
| Other Applications | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Stable Isotope Labeled Compounds Market Research FAQs
What is the current Stable Isotope Labeled Compounds Market size?
The Stable Isotope Labeled Compounds Market is projected to register a CAGR of 3.30% during the forecast period (2024-2029)
Who are the key players in Stable Isotope Labeled Compounds Market?
PerkinElmer Inc, Merck KGaA, Cambridge Isotope Laboratories, Inc., JSC Isotope. and Medical Isotopes, Inc. are the major companies operating in the Stable Isotope Labeled Compounds Market.
Which is the fastest growing region in Stable Isotope Labeled Compounds Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Stable Isotope Labeled Compounds Market?
In 2024, the North America accounts for the largest market share in Stable Isotope Labeled Compounds Market.
What years does this Stable Isotope Labeled Compounds Market cover?
The report covers the Stable Isotope Labeled Compounds Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Stable Isotope Labeled Compounds Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Isotope Labelled Compounds Industry Report
Statistics for the 2024 Isotope Labelled Compounds market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Isotope Labelled Compounds analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
